| 1 |
Dogan Y, Kara M, Dogan KC, Kaymak B, Ozcakar L. Neuralgic amyotrophy associated with COVID-19 infection: the broken bough. Korean J Pain 2022; 35: 233-5.
DOI
|
| 2 |
McWilliam M, Samuel M, Alkufri FH. Neuropathic pain postCOVID-19: a case report. BMJ Case Rep 2021; 14: e243459.
DOI
|
| 3 |
Jena D, Sahoo J, Barman A, Dalai A, Patel S. Neuropathic pain in hospitalized patients with COVID-19: a prospective case series. Arch Rehabil Res Clin Transl 2022; 4: 100188.
|
| 4 |
Cattaneo C, Pagliarini E, Mambrini SP, Tortorici E, Mene R, Torlasco C, et al. Changes in smell and taste perception related to COVID-19 infection: a case-control study. Sci Rep 2022; 12: 8192.
DOI
|
| 5 |
John H, Lim YH, Hong SJ, Jeong JH, Choi HR, Park SK, et al. Impact of coronavirus disease 2019 on patients with chronic pain: multicenter study in Korea. Korean J Pain 2022; 35: 209-23.
DOI
|
| 6 |
Odozor CU, Roles K, Burk C, Kannampallil T, Clifford DB, Piccirillo JF, et al. Cohort study protocol to characterize the incidence and severity of neuropathic pain in patients with severe acute respiratory syndrome coronavirus 2 infection. Pain Rep 2021; 6: e925.
DOI
|
| 7 |
Branavan B, Indrakumar J. Possible complex regional pain syndrome following SARS-CoV-2 infection: case report. SAGE Open Med Case Rep 2022; 10: 2050313X221093111.
|
| 8 |
Guerrero JI, Barragan LA, Martinez JD, Montoya JP, Pena A, Sobrino FE, et al. Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. BMC Infect Dis 2021; 21: 515.
DOI
|
| 9 |
WHO. Weekly epidemiological update on COVID-19 - 25 May 2022 [Internet]. Geneva: WHO; 2022. Available at: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---25-may-2022.
|
| 10 |
Alonso-Matielo H, da Silva Oliveira VR, de Oliveira VT, Dale CS. Pain in Covid era. Front Physiol 2021; 12: 624154.
DOI
|
| 11 |
Sivan M, Taylor S. NICE guideline on long covid. BMJ 2020; 371: m4938.
DOI
|
| 12 |
Cascella M, Del Gaudio A, Vittori A, Bimonte S, Del Prete P, Forte CA, et al. COVID-pain: acute and late-onset painful clinical manifestations in COVID-19 - molecular mechanisms and research perspectives. J Pain Res 2021; 14: 2403-12.
DOI
|
| 13 |
Attal N, Martinez V, Bouhassira D. Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic. Pain Rep 2021; 6: e884.
DOI
|
| 14 |
McFarland AJ, Yousuf MS, Shiers S, Price TJ. Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain. Pain Rep 2021; 6: e885.
DOI
|
| 15 |
Herrero-Montes M, Fernandez-de-Las-Penas C, FerrerPargada D, Tello-Mena S, Cancela-Cilleruelo I, Rodriguez-Jimenez J, et al. Prevalence of neuropathic component in post-COVID pain symptoms in previously hospitalized COVID-19 survivors. Int J Clin Pract 2022; 2022: 3532917.
|
| 16 |
Ojeda A, Calvo A, Cunat T, Mellado-Artigas R, Comino-Trinidad O, Aliaga J, et al. Characteristics and influence on quality of life of new-onset pain in critical COVID-19 survivors. Eur J Pain 2022; 26: 680-94.
DOI
|
| 17 |
Shehab D, Abdulsalam AJ, Reebye RN. Complex Regional Pain Syndrome as a sequala of COVID-19 pneumonia. Rev Neurol (Paris) 2022. doi: 10.1016/j.neurol.2022.03.013.
DOI
|
| 18 |
Vaz A, Costa A, Pinto A, Silva AI, Figueiredo P, Sarmento A, et al. Complex regional pain syndrome after severe COVID-19 - a case report. Heliyon 2021; 7: e08462.
DOI
|
webmaster
